Validity of two scales in identifying HIV-associated dementia

被引:0
|
作者
Berghuis, JP
Uldall, KK
Lalonde, B
机构
[1] Univ Washington, Innovat Programs, Sch Social Work, Dept Psychiat & Behav Sci, Seattle, WA 98105 USA
[2] Univ Washington, Dept Hlth Sci, Seattle, WA 98105 USA
关键词
HIV AIDS; dementia; HIV dementia scale; executive interview; neuropsychology;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: To examine and compare the validity of the HIV Dementia Scale (HDS) and Executive Interview (EXIT) in detecting HIV/AIDS dementia. Methods: The sample included hospitalized or skilled nursing/assisted-living facility (SNF) HIV/AIDS patients (N = 103). Participants completed the HDS, EXIT, and the Structured Clinical Interview from the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). A chart review also was performed. Results: Sample was predominantly male (93%) and white (79%), with a mean age of 38 years (standard deviation [SD] 8 years). Twelve patients had a clinical diagnosis of HIV dementia. Cutoff scores of 10 or less for the HDS and 11 or more for the EXIT optimized sensitivity and specificity. Education level was related to performance for both tests. Using separate logistic regression analyses, the HDS and the EXIT were significant individual predictors of dementia. When entered together, the EXIT was the only significant predictor of dementia. Selected items of the HDS and EXIT also performed well in identifying patients with dementia. Conclusions: The HDS and the EXIT show promise as brief, well-tolerated screening tools for HIV dementia in ill patients. The HDS was more sensitive, but the EXIT added additional predictive power over the HDS in identifying dementia.
引用
收藏
页码:134 / 140
页数:7
相关论文
共 50 条
  • [1] HIV-associated dementia
    Major, EO
    Rausch, D
    Marra, C
    Clifford, D
    SCIENCE, 2000, 288 (5465) : 440 - 441
  • [2] Pathogenesis of HIV-associated dementia
    不详
    INFECTIONS IN MEDICINE, 1997, 14 (06) : 488 - 489
  • [3] Delirium in HIV-associated dementia
    Kapetanovic, Suad
    Simpson, George M.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (07): : 767 - 768
  • [4] Immunopathogenesis of HIV-associated dementia
    Wesselingh, SL
    Thompson, KA
    CURRENT OPINION IN NEUROLOGY, 2001, 14 (03) : 375 - 379
  • [5] HIV-associated dementia - Response
    Gartner, S
    McArthur, JC
    SCIENCE, 2000, 288 (5465) : 441 - 442
  • [6] HIV-Associated Vacuolar Myelopathy and HIV-Associated Dementia as the Initial Manifestation of HIV/AIDS
    Wuliji, Natalia
    Mandell, Matthew J.
    Lunt, Jason M.
    Merando, Adam
    CASE REPORTS IN INFECTIOUS DISEASES, 2019, 2019
  • [7] Identifying Risk Factors for HIV-Associated Neurocognitive Disorders Using the International HIV Dementia Scale
    Cross, Sara
    Oenen, Nur
    Gase, Amber
    Overton, Edgar Turner
    Ances, Beau M.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2013, 8 (05) : 1114 - 1122
  • [8] Drugs of Abuse, Dopamine, and HIV-Associated Neurocognitive Disorders/HIV-Associated Dementia
    Vishnudutt Purohit
    Rao Rapaka
    David Shurtleff
    Molecular Neurobiology, 2011, 44 : 102 - 110
  • [9] Drugs of Abuse, Dopamine, and HIV-Associated Neurocognitive Disorders/HIV-Associated Dementia
    Purohit, Vishnudutt
    Rapaka, Rao
    Shurtleff, David
    MOLECULAR NEUROBIOLOGY, 2011, 44 (01) : 102 - 110
  • [10] Identifying Risk Factors for HIV-Associated Neurocognitive Disorders Using the International HIV Dementia Scale
    Sara Cross
    Nur Önen
    Amber Gase
    Edgar Turner Overton
    Beau M. Ances
    Journal of Neuroimmune Pharmacology, 2013, 8 : 1114 - 1122